TVRD
Tvardi Therapeutics
TVRD
TVRD
127 hedge funds and large institutions have $211M invested in Tvardi Therapeutics in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 28 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $262M → $211M (-$50.5M)
28% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 39
30% less call options, than puts
Call options by funds: $4.36M | Put options by funds: $6.24M
Holders
127
Holding in Top 10
1
Calls
$4.36M
Puts
$6.24M
Top Buyers
| 1 | +$5.5M | |
| 2 | +$2.34M | |
| 3 | +$1.63M | |
| 4 |
First Manhattan
New York
|
+$1.25M |
| 5 |
Millennium Management
New York
|
+$1.14M |
Top Sellers
| 1 | -$20M | |
| 2 | -$3.48M | |
| 3 | -$3.19M | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$2.12M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$1.95M |